 | • レポートコード：GIR201111427 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、グルカゴン様ペプチド2受容体の世界市場を調査対象にし、グルカゴン様ペプチド2受容体の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（FE-203799、グレパグルチド、GXG-8、HM-15910、その他）、用途別分析（短腸症候群、糖尿病、下痢、肥満、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Hanmi Pharmaceuticals Co Ltd、Tasly Pharmaceutical Group Co Ltd、Naia Ltd、Takeda、Zealand Pharma AS ・メーカー別販売量、売上、市場シェア ・グルカゴン様ペプチド2受容体の地域別市場分析 ・グルカゴン様ペプチド2受容体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・グルカゴン様ペプチド2受容体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・グルカゴン様ペプチド2受容体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・グルカゴン様ペプチド2受容体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・グルカゴン様ペプチド2受容体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・グルカゴン様ペプチド2受容体の種類別市場規模2015-2020：FE-203799、グレパグルチド、GXG-8、HM-15910、その他 ・グルカゴン様ペプチド2受容体の用途別市場規模2015-2020：短腸症候群、糖尿病、下痢、肥満、その他 ・グルカゴン様ペプチド2受容体の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Glucagon Like Peptide 2 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Glucagon Like Peptide 2 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Glucagon Like Peptide 2 Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Glucagon Like Peptide 2 Receptor market has been segmented into
FE-203799
Glepaglutide
GXG-8
HM-15910
Others
By Application, Glucagon Like Peptide 2 Receptor has been segmented into:
Short Bowel Syndrome
Diabetes
Diarrhea
Obesity
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Glucagon Like Peptide 2 Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Glucagon Like Peptide 2 Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Glucagon Like Peptide 2 Receptor market.
The report offers in-depth assessment of the growth and other aspects of the Glucagon Like Peptide 2 Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Glucagon Like Peptide 2 Receptor Market Share Analysis
Glucagon Like Peptide 2 Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Glucagon Like Peptide 2 Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Glucagon Like Peptide 2 Receptor sales, revenue and market share for each player covered in this report.
The major players covered in Glucagon Like Peptide 2 Receptor are:
Hanmi Pharmaceuticals Co Ltd
Tasly Pharmaceutical Group Co Ltd
Naia Ltd
Takeda
Zealand Pharma AS
Among other players domestic and global, Glucagon Like Peptide 2 Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glucagon Like Peptide 2 Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glucagon Like Peptide 2 Receptor, with price, sales, revenue and global market share of Glucagon Like Peptide 2 Receptor in 2018 and 2019.
Chapter 3, the Glucagon Like Peptide 2 Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glucagon Like Peptide 2 Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Glucagon Like Peptide 2 Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Glucagon Like Peptide 2 Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Glucagon Like Peptide 2 Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glucagon Like Peptide 2 Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 FE-203799
1.2.3 Glepaglutide
1.2.4 GXG-8
1.2.5 HM-15910
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Glucagon Like Peptide 2 Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Short Bowel Syndrome
1.3.3 Diabetes
1.3.4 Diarrhea
1.3.5 Obesity
1.3.6 Others
1.4 Overview of Global Glucagon Like Peptide 2 Receptor Market
1.4.1 Global Glucagon Like Peptide 2 Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hanmi Pharmaceuticals Co Ltd
2.1.1 Hanmi Pharmaceuticals Co Ltd Details
2.1.2 Hanmi Pharmaceuticals Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Hanmi Pharmaceuticals Co Ltd SWOT Analysis
2.1.4 Hanmi Pharmaceuticals Co Ltd Product and Services
2.1.5 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Tasly Pharmaceutical Group Co Ltd
2.2.1 Tasly Pharmaceutical Group Co Ltd Details
2.2.2 Tasly Pharmaceutical Group Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Tasly Pharmaceutical Group Co Ltd SWOT Analysis
2.2.4 Tasly Pharmaceutical Group Co Ltd Product and Services
2.2.5 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Naia Ltd
2.3.1 Naia Ltd Details
2.3.2 Naia Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Naia Ltd SWOT Analysis
2.3.4 Naia Ltd Product and Services
2.3.5 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takeda
2.4.1 Takeda Details
2.4.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takeda SWOT Analysis
2.4.4 Takeda Product and Services
2.4.5 Takeda Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zealand Pharma AS
2.5.1 Zealand Pharma AS Details
2.5.2 Zealand Pharma AS Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zealand Pharma AS SWOT Analysis
2.5.4 Zealand Pharma AS Product and Services
2.5.5 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Glucagon Like Peptide 2 Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Glucagon Like Peptide 2 Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon Like Peptide 2 Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Glucagon Like Peptide 2 Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Glucagon Like Peptide 2 Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Glucagon Like Peptide 2 Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
4.5 South America Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Glucagon Like Peptide 2 Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Glucagon Like Peptide 2 Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Glucagon Like Peptide 2 Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Glucagon Like Peptide 2 Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
6.3 UK Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
6.4 France Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7.5 India Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Glucagon Like Peptide 2 Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Glucagon Like Peptide 2 Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Glucagon Like Peptide 2 Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Glucagon Like Peptide 2 Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Glucagon Like Peptide 2 Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Glucagon Like Peptide 2 Receptor Price by Type (2015-2020)
11 Global Glucagon Like Peptide 2 Receptor Market Segment by Application
11.1 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
11.2 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Glucagon Like Peptide 2 Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Glucagon Like Peptide 2 Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Glucagon Like Peptide 2 Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025)
12.2.2 Europe Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025)
12.2.4 South America Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025)
12.3 Glucagon Like Peptide 2 Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Glucagon Like Peptide 2 Receptor Market Share Forecast by Type (2021-2025)
12.4 Glucagon Like Peptide 2 Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Glucagon Like Peptide 2 Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Glucagon Like Peptide 2 Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Glucagon Like Peptide 2 Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Hanmi Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Major Business
Table 9. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Hanmi Pharmaceuticals Co Ltd SWOT Analysis
Table 11. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 12. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Tasly Pharmaceutical Group Co Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Major Business
Table 15. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Tasly Pharmaceutical Group Co Ltd SWOT Analysis
Table 17. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 18. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Naia Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Naia Ltd Glucagon Like Peptide 2 Receptor Major Business
Table 21. Naia Ltd Glucagon Like Peptide 2 Receptor Total Revenue (USD Million) (2018-2019)
Table 22. Naia Ltd SWOT Analysis
Table 23. Naia Ltd Glucagon Like Peptide 2 Receptor Product and Services
Table 24. Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Takeda Basic Information, Manufacturing Base and Competitors
Table 26. Takeda Glucagon Like Peptide 2 Receptor Major Business
Table 27. Takeda Glucagon Like Peptide 2 Receptor Total Revenue (USD Million) (2018-2019)
Table 28. Takeda SWOT Analysis
Table 29. Takeda Glucagon Like Peptide 2 Receptor Product and Services
Table 30. Takeda Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Zealand Pharma AS Basic Information, Manufacturing Base and Competitors
Table 32. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Major Business
Table 33. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Total Revenue (USD Million) (2018-2019)
Table 34. Zealand Pharma AS SWOT Analysis
Table 35. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product and Services
Table 36. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Glucagon Like Peptide 2 Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Glucagon Like Peptide 2 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Regions (2015-2020)
Table 41. Global Glucagon Like Peptide 2 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Glucagon Like Peptide 2 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Countries (2015-2020)
Table 44. North America Glucagon Like Peptide 2 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020)
Table 46. Europe Glucagon Like Peptide 2 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Countries (2015-2020)
Table 48. Europe Glucagon Like Peptide 2 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Glucagon Like Peptide 2 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Glucagon Like Peptide 2 Receptor Sales Market Share by Countries (2015-2020)
Table 54. South America Glucagon Like Peptide 2 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020)
Table 60. Global Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Global Glucagon Like Peptide 2 Receptor Sales Share by Type (2015-2020)
Table 62. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2015-2020) (USD Million)
Table 63. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2015-2020)
Table 64. Global Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 65. Global Glucagon Like Peptide 2 Receptor Sales Share by Application (2015-2020)
Table 66. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Glucagon Like Peptide 2 Receptor Market Share Forecast by Regions (2021-2025)
Table 68. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Glucagon Like Peptide 2 Receptor Market Share Forecast by Type (2021-2025)
Table 70. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2021-2025)
Table 71. Global Glucagon Like Peptide 2 Receptor Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Glucagon Like Peptide 2 Receptor Picture
Figure 2. Global Sales Market Share of Glucagon Like Peptide 2 Receptor by Type in 2019
Figure 3. FE-203799 Picture
Figure 4. Glepaglutide Picture
Figure 5. GXG-8 Picture
Figure 6. HM-15910 Picture
Figure 7. Others Picture
Figure 8. Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2018
Figure 9. Short Bowel Syndrome Picture
Figure 10. Diabetes Picture
Figure 11. Diarrhea Picture
Figure 12. Obesity Picture
Figure 13. Others Picture
Figure 14. Global Glucagon Like Peptide 2 Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Glucagon Like Peptide 2 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturer in 2019
Figure 35. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Glucagon Like Peptide 2 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Glucagon Like Peptide 2 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Regions (2015-2020)
Figure 42. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Regions in 2018
Figure 43. North America Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
Figure 44. Europe Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
Figure 46. South America Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020)
Figure 48. North America Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Countries (2015-2020)
Figure 50. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Countries in 2018
Figure 51. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries in 2018
Figure 53. United States Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries in 2019
Figure 59. Germany Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Regions 2019
Figure 67. China Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Glucagon Like Peptide 2 Receptor Sales Market Share by Countries in 2019
Figure 74. South America Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries in 2019
Figure 75. Brazil Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Glucagon Like Peptide 2 Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Glucagon Like Peptide 2 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
グルカゴン様ペプチド-2（GLP-2）アゴニストの世界市場 2020年 Market Overview The global Glucagon-like Peptide-2 (GLP-2) Agonist market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gluca…- グルカゴン様ペプチド-1（GLP-1）アゴニストの世界市場 2020年 Market Overview The Glucagon Like Peptide-1 (GLP-1) Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- N-ホルミルペプチド受容体2の世界市場 2020年 Market Overview The global N-Formyl Peptide Receptor 2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The N-Formyl Peptide …
- グルカゴンの世界市場 2020年 Market Overview The Glucagon market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 卵白ペプチドの世界市場 2020年 Market Overview The global Egg White Peptide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Egg White Peptide market re…